SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-025805
Filing Date
2024-07-01
Accepted
2024-07-01 16:30:39
Documents
14
Period of Report
2024-07-01
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40806
  Complete submission text file 0001493152-24-025805.txt   262237

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cdt-20240701.xsd EX-101.SCH 3883
3 XBRL DEFINITION FILE cdt-20240701_def.xml EX-101.DEF 26778
4 XBRL LABEL FILE cdt-20240701_lab.xml EX-101.LAB 37007
5 XBRL PRESENTATION FILE cdt-20240701_pre.xml EX-101.PRE 25402
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6200
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41245 | Film No.: 241091076
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)